Adaptive Naming Treatment Schedules for Aphasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new methods to help people with aphasia, a language disorder often caused by stroke, improve their ability to find and use words in everyday life. The study tests various methods of teaching word naming through pictures, focusing on how well participants remember and use these words over time. Participants will try three different treatment schedules, including the Adaptive Spacing Condition, to determine which most effectively aids word retention and daily use. The trial seeks individuals who have experienced aphasia for more than six months following a left hemisphere stroke and have access to high-speed internet for telehealth participation. As a Phase 2 trial, the research measures the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to significant advancements in aphasia treatment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that the adaptive naming treatment methods tested in this study are generally safe for people with aphasia. Although specific safety details aren't always highlighted in existing research, similar treatments have been used without major safety concerns.
For the adaptive spacing condition, available studies have not reported specific safety issues. Previous research indicates that adaptive methods are effective and manageable for people with aphasia, suggesting they are well-tolerated.
For the high-item and low-item non-adaptive spacing conditions, studies have shown positive effects on word-finding abilities without noting any negative effects, indicating these methods are likely safe.
Since this trial is in a middle stage, earlier studies have likely demonstrated a good level of safety. However, participants should still pay attention to any specific instructions or potential risks provided by the trial team.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments for aphasia because they explore different ways to improve language recovery through varied naming practice schedules. Unlike the standard approach, which often involves repetitive speech therapy exercises, these new methods use adaptive and non-adaptive spacing to enhance learning. Adaptive spacing adjusts to the individual's progress, potentially making treatment more personalized and effective. By testing combinations of high-item and low-item non-adaptive spacing, researchers aim to find the most efficient way to help patients regain their naming abilities, offering hope for more tailored and impactful aphasia rehabilitation strategies.
What evidence suggests that this trial's treatments could be effective for aphasia?
Research has shown that spreading out practice sessions over time, known as adaptive spacing, can help people with aphasia learn better. This trial will evaluate different naming treatment conditions, including adaptive and non-adaptive spacing methods. Studies have found that treatments focused on naming pictures, whether using adaptive spacing or not, can significantly improve naming ability. Both high and low amounts of practice, when conducted through telepractice (online sessions), are as effective as in-person sessions. Additionally, digital therapies have led to an average improvement of 29 more words. Overall, these methods show promise in helping people with aphasia find words more easily.12567
Who Is on the Research Team?
William Evans, PhD
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for people who have had a stroke leading to aphasia, a language disorder, and struggle with finding words. They must be at least six months post-stroke, show specific difficulties on the Comprehensive Aphasia Test, and can use telehealth services via high-speed internet. It's not for those with other neurological diseases, severe comprehension issues, uncontrolled substance dependence or serious mood disorders.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 10 weeks of computer-based training per condition, including one-on-one and independent practice sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment with probes administered at baseline and at 1 week, 3 months, and 6 months post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- Adaptive Spacing Condition
- High-Item Non-Adaptive Spacing Condition
- Low-Item Non-Adaptive Spacing Condition
Adaptive Spacing Condition is already approved in United States for the following indications:
- Aphasia
- Anomia
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
University of Massachusetts, Amherst
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator